Genetics and Insurance: What have we Learned So Far?
From MaRDI portal
Publication:5467679
DOI10.1080/03461230110106426zbMath1092.91052OpenAlexW2057579648MaRDI QIDQ5467679
Publication date: 24 May 2006
Published in: Scandinavian Actuarial Journal (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/03461230110106426
Related Items
Premium rates based on genetic studies: How reliable are they? ⋮ Adult Polycystic Kidney Disease and Insurance ⋮ The Genetics of Breast and Ovarian Cancer III: A new model of family history with insurance applications
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Mathematical and statistical methods for genetic analysis
- Analysis of multivariate survival data
- A Nelson-Aalen Estimate of the Incidence Rates of Early-Onset Alzheimer's Disease Associated with the Presenilin-1 Gene
- The Value of the Aggregate Data Approach in Meta-Analysis with Time-to-Event Outcomes
- Adult Polycystic Kidney Disease and Critical Illness Insurance
- Pricing Term Insurance in the Presence of a Family History of Breast or Ovarian Cancer
- Genetics, Alzheimer’s Disease, and Long-Term Care Insurance
- Modeling the Impact of Genetics on Insurance
- Statistical models based on counting processes
This page was built for publication: Genetics and Insurance: What have we Learned So Far?